Viral Hepatitis
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6518-6528
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6518
Table 2 Relationship between cryoglobulin-positivity and the presence (%) of extrahepatic manifestations in patients with chronic HCV infection
ExtrahepaticmanifestationsCryoglobulin-positivepatients (n = 51)Cryoglobulin-negativepatients (n = 85)POdds ratio(95% confidence interval)
Fatigue92.240.00.00017.6 (5.8-53.4)
Purpura41.23.50.00019.1 (5.3-68.8)
Raynaud' phenomenon25.53.50.0009.3 (2.5-34.7)
Arthralgia33.39.40.0014.8 (1.8-12.2)
Paresthesia41.27.10.0009.2 (3.3-25.0)
Renal involvement45.112.40.0005.5 (2.3-12.7)
Type 2 diabetes35.315.30.0113.0 (1.3-6.8)
Lymphadenomegaly35.34.70.00011.0 (3.4-35.1)
Lymphoma17.63.50.0155.8 (1.5-22.7)
Pulmonary fibrosis25.59.40.0153.2 (1.2-8.6)
Thyroid dysfunction15.714.1
Xerostomia11.83.5
Lichen planus7.84.7
Thrombocytopenia58.815.30.0007.9 (3.5-17.8)
ANA29.411.80.0133.1 (1.2-76.0)
ASMA33.37.10.0006.5 (2.3-18.1)
ANCA25.55.90.0025.4 (1.9-16.4)
ACL-antibodies17.63.50.0105.8 (1.5-22.7)